RxSight, Inc.
RXST
$14.19
$0.886.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.55M | -27.46M | -30.69M | -36.77M | -44.50M |
| Total Depreciation and Amortization | 3.27M | 3.62M | 4.19M | 4.17M | 4.38M |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 4.00K | 146.00K |
| Total Other Non-Cash Items | 17.58M | 16.10M | 14.37M | 14.27M | 12.81M |
| Change in Net Operating Assets | -10.77M | -9.21M | -8.85M | -11.30M | -5.98M |
| Cash from Operations | -16.47M | -16.95M | -20.99M | -29.62M | -33.14M |
| Capital Expenditure | -4.05M | -5.44M | -6.18M | -5.73M | -6.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.68M | -93.87M | -89.88M | -63.80M | 56.54M |
| Cash from Investing | -102.73M | -99.31M | -96.07M | -69.53M | 50.51M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 20.00M |
| Total Debt Repaid | -47.00K | -61.00K | -83.00K | -20.11M | -60.14M |
| Issuance of Common Stock | 119.46M | 128.92M | 129.51M | 139.61M | 50.20M |
| Repurchase of Common Stock | -4.05M | -4.77M | -4.77M | -3.22M | -3.22M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -768.00K | -768.00K | -754.00K | -1.49M | -2.63M |
| Cash from Financing | 114.59M | 123.32M | 123.91M | 114.79M | 4.21M |
| Foreign Exchange rate Adjustments | 0.00 | -9.00K | 11.00K | -1.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1.00K | 0.00 | 0.00 |
| Net Change in Cash | -4.61M | 7.05M | 6.86M | 15.64M | 21.58M |